Cargando…

Drug Company Advertising in Medical Journals About the Health-Economic Advantages of Their Products for 2000-2006 Versus 1990-1999

BACKGROUND: Section 114 of the 1997 Food and Drug Administration Modernization Act (FDAMA) effective February 19, 1998, permitted some additional flexibility for drug companies to provide health care economic information to a formulary committee or other similar entity and may have caused a decline...

Descripción completa

Detalles Bibliográficos
Autores principales: Palmer, Jennifer A., Timm, Alison R., Neumann, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438268/
https://www.ncbi.nlm.nih.gov/pubmed/18983204
http://dx.doi.org/10.18553/jmcp.2008.14.8.749